dx 9065a has been researched along with Cardiovascular Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaiser, B | 1 |
| Alexander, J; Becker, RC; Dyke, CK; Harrington, RA | 1 |
| Becker, RC; Spencer, FA | 1 |
3 review(s) available for dx 9065a and Cardiovascular Diseases
| Article | Year |
|---|---|
DX-9065a, a direct inhibitor of factor Xa.
Topics: Animals; Anticoagulants; Biological Availability; Bleeding Time; Cardiovascular Diseases; Clinical Trials as Topic; Drug Administration Routes; Drug Evaluation, Preclinical; Factor Xa Inhibitors; Humans; Naphthalenes; Propionates | 2003 |
Development of DX-9065a, a novel direct factor Xa antagonist, in cardiovascular disease.
Topics: Animals; Anticoagulants; Area Under Curve; Blood Coagulation; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Artery Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Factor Xa; Factor Xa Inhibitors; Humans; International Normalized Ratio; Mice; Models, Biological; Models, Chemical; Naphthalenes; Pilot Projects; Platelet Aggregation Inhibitors; Propionates; Rats; Thrombin; Thromboplastin; Thrombosis; Time Factors | 2004 |
Novel inhibitors of factor X for use in cardiovascular diseases.
Topics: Animals; Antithrombin III; Arthropod Proteins; Cardiovascular Diseases; Factor X; Factor Xa Inhibitors; Fibrinolytic Agents; Helminth Proteins; Heparin, Low-Molecular-Weight; Humans; Intercellular Signaling Peptides and Proteins; Invertebrate Hormones; Leeches; Naphthalenes; Oligosaccharides; Peptides; Piperidines; Propionates | 2000 |